| Delatestryl Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Delatestryl enanthate 200 mg/mL | solution | intramuscular | 1.0 milliliter(s) | OTC |
Market Review: Indevus Pharmaceuticals, Inc. Under Current ... - Trading Markets (press release)
... for overactive bladder, VANTAS for advanced prostate cancer, SUPPRELIN LA for central precocious puberty, and DELATESTRYL to treat male hypogonadism. ...
Fri Feb 01 05:40:54 -0500 2008
Indevus To Announce First Quarter Fiscal 2008 Financial Results On ... - FOXBusiness
... VANTAS, SUPPRELIN LA, DELATESTRYL and any future products; acceptance by the healthcare community of our approved products and product candidates; ...
Thu Jan 31 13:43:48 -0500 2008
Alkermes and Indevus Announce Positive Results from Phase 2a ... - Genetic Engineering News (press release)
DELATESTRYL(R) is Indevus' registered trademark for its DELATESTRYL product. VANTAS(R) is Indevus' registered trademark for its VANTAS product. ...
Wed Sep 26 05:27:44 -0400 2007
testosterone enanthate - A long-acting intramuscular form of the androgen testosterone. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels. In addition, this agent promotes the maintenance of male sex characteristics and is indicated for testosterone replacement in hypogonadal males, delayed puberty, and metastatic mammary cancer. (NCI04)